BF Biosciences Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2019 - 2020
Cash & Equivalents	251.12	344.47	278.77	255.44	211.67	421.69	Upgrade
Short-Term Investments	86.75	-	-	147.39	1,498	848.82	Upgrade
Trading Asset Securities	1,299	1,167	39.01	-	-	-	Upgrade
Cash & Short-Term Investments	1,637	1,511	317.78	402.83	1,710	1,271	Upgrade
Cash Growth	-26.44%	375.55%	-21.11%	-76.44%	34.58%	139.20%	Upgrade
Accounts Receivable	571.17	184.24	204.61	93.81	52.71	202.49	Upgrade
Other Receivables	-	45.51	49.33	49.64	-	-	Upgrade
Receivables	571.17	229.75	253.94	143.45	67.93	230.01	Upgrade
Inventory	1,790	1,740	893.81	852.24	406.55	356.16	Upgrade
Prepaid Expenses	-	5.34	5.88	2.28	-	-	Upgrade
Other Current Assets	416.6	349.88	205.26	190.5	110.93	98.97	Upgrade
Total Current Assets	4,415	3,836	1,677	1,591	2,295	1,956	Upgrade
Property, Plant & Equipment	4,304	4,306	4,175	4,070	2,135	1,034	Upgrade
Other Intangible Assets	3.56	3.98	0.55	1.11	-	-	Upgrade
Other Long-Term Assets	11.85	11.85	7.83	4.83	4.83	4.83	Upgrade
Total Assets	8,734	8,159	5,860	5,667	4,435	2,995	Upgrade
Accounts Payable	1,413	321.12	269.06	225.38	394.28	401.74	Upgrade
Accrued Expenses	13.29	541.51	266.09	144.7	13.82	6.74	Upgrade
Short-Term Debt	147.05	29.36	328.7	473.39	149.35	-	Upgrade
Current Portion of Long-Term Debt	331.93	328.05	292.72	356.88	57.65	16.32	Upgrade
Current Unearned Revenue	146.35	134.26	150.87	135.59	99.86	41.6	Upgrade
Other Current Liabilities	-	269.97	121.15	67.02	-	-	Upgrade
Total Current Liabilities	2,052	1,624	1,429	1,403	714.96	466.4	Upgrade
Long-Term Debt	1,328	1,367	1,591	1,772	1,537	873.06	Upgrade
Long-Term Unearned Revenue	291.59	318.37	432.6	503.73	331.33	172.67	Upgrade
Long-Term Deferred Tax Liabilities	240.87	186.58	48.31	13.51	26.55	15.99	Upgrade
Total Liabilities	3,912	3,497	3,500	3,693	2,610	1,528	Upgrade
Common Stock	265	265	190	190	190	190	Upgrade
Additional Paid-In Capital	1,780	1,780	-	-	-	-	Upgrade
Retained Earnings	2,776	2,617	2,170	1,784	1,502	1,200	Upgrade
Comprehensive Income & Other	-	-	-	-	132.7	76.27	Upgrade
Shareholders' Equity	4,821	4,662	2,360	1,974	1,825	1,467	Upgrade
Total Liabilities & Equity	8,734	8,159	5,860	5,667	4,435	2,995	Upgrade
Total Debt	1,807	1,725	2,212	2,603	1,744	889.38	Upgrade
Net Cash (Debt)	-169.83	-213.54	-1,894	-2,200	-34.26	381.13	Upgrade
Net Cash Growth	-	-	-	-	-	-27.32%	Upgrade
Net Cash Per Share	-1.95	-2.64	-29.91	-34.74	-0.54	6.02	Upgrade
Filing Date Shares Outstanding	88.33	88.33	63.33	63.33	63.33	63.33	Upgrade
Total Common Shares Outstanding	88.33	88.33	63.33	63.33	63.33	63.33	Upgrade
Working Capital	2,363	2,212	248.08	188.34	1,580	1,489	Upgrade
Book Value Per Share	54.58	52.78	37.26	31.17	28.82	23.16	Upgrade
Tangible Book Value	4,818	4,658	2,359	1,973	1,825	1,467	Upgrade
Tangible Book Value Per Share	54.54	52.73	37.25	31.15	28.82	23.16	Upgrade
Land	-	25.36	25.36	25.36	-	-	Upgrade
Buildings	-	993.57	236.06	214.16	-	-	Upgrade
Machinery	-	4,131	1,191	708.94	-	-	Upgrade
Construction In Progress	52.39	133.03	3,516	3,884	-	-	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.